$KMB

Kimberly-Clark sales rise 0.6% to $4.2 billion

Kimberly-Clark reported Q2 net sales of $4.2 billion, up 0.6% year over year. Adjusted EPS rose 10.4% to $2.12, and adjusted operating profit increased 6.2% to $757 million. The company revised its 2026 outlook after a disruption affected diaper sales in China. Shares were down 1.5% in premarket.

Original reporting
Published Aug 4, 2026, 3:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kimberly-Clark sales rise 0.6% to $4.2 billion — source image
Decision brief

The 30-second read

$KMBNeutralMed
01

Why it matters

Traders should focus on how the China disruption flows through to the revised 2026 outlook and whether margin tailwinds (tariff refunds, productivity) are sustainable versus one-off benefits.

02

Market read

Q2 beat on adjusted EPS and margin expansion is being weighed against a China-driven outlook revision, producing a pre-market selloff despite improved profitability metrics.

03

What to watch

The article also notes the Arbex JV with Suzano and progress on the Kenvue acquisition; these could partially offset near-term China concerns if investors focus on longer-term portfolio and cost synergies.

Relevance 7/10Novelty 6/10Timing: pre-market today, after Q2 results and 2026 outlook revision

Background

Kimberly-Clark is reporting second-quarter results and addressing demand disruption in China’s diaper business, alongside corporate development items (Arbex JV, Kenvue acquisition progress).

Company-level read

Ticker impact

$KMBNeutralMedium confidence
Context

Kimberly-Clark reported Q2 net sales of $4.2B and adjusted EPS of $2.12, and revised its 2026 outlook after China diaper disruption.

Expected impact

Likely choppy follow-through after-hours and into the next session, with direction depending on how investors interpret the China disruption and margin drivers.

Evidence & confidence

The article provides specific Q2 datapoints (sales, adjusted EPS, margin) and a new guidance revision rationale (China disruption), which typically drives estimate changes and positioning. However, it does not include the magnitude of the outlook change, limiting precision.

Market effects

Signals ongoing volatility in consumer staples personal care/diaper demand in China, which can affect read-across for peers’ emerging-market volume expectations.

China diaper disruption is the explicit driver, raising sensitivity to China-specific demand and supply-chain normalization.

Tariff refunds and productivity savings supporting gross margin suggest global cost actions may offset some demand softness, influencing broader margin expectations in the sector.

Counterpoint

The margin expansion (38.8% adjusted gross margin) and productivity/tariff refunds may indicate the China disruption is contained, so the market may be over-discounting the guidance risk.

Key entities

  • Kimberly-Clark

    Reported Q2 net sales and adjusted EPS, revised 2026 outlook due to China diaper disruption, and outlined margin drivers and corporate actions.

  • Suzano

    Partnered with Kimberly-Clark on the Arbex joint venture mentioned in the article.

  • Kenvue

    Kimberly-Clark’s acquisition of Kenvue is stated to remain on track to close by year-end, subject to approvals.

Related articles

$KMBMed

Kimberly-Clark to Consolidate Operations, Invest in Digital Optimizations Ahead of Kenvue Acquisition

Kimberly-Clark said it will consolidate 6,000 applications and more than 15 ERP systems as it nears completion of its Kenvue acquisition. On an earnings call, COO Russell Torres cited a three-year plan targeting $1.9 million in savings and identified over $600 million of savings, with system integration and supply chain and commercial integration as key drivers.

$KMBMedAI 8/10

False Quality Claims Threaten Kimberly-Clarks Diaper Sales in China: Repercussions and Recovery Strategies

Kimberly-Clark (maker of Huggies) cut its annual profit and sales outlook after social media allegations in China claimed Huggies diapers contained formamide, hurting Q2 sales. The company commissioned an independent government-approved test that refuted the claims, while regulators are investigating. It now expects 2026 organic sales growth about 100 bps below peers and adjusted EPS growth in high single digits.

$KMBMedAI 8/10

Kimberly-Clark Q2 Earnings Call Highlights

Kimberly-Clark (KMB) discussed Q2 results and guidance on an earnings call. Management cited China diaper disruption starting late June as a headwind to organic sales and said it expects about a $70 million operating profit and $0.16 EPS impact in H2. North America shipments fell 1.4% vs consumption up 0.3%, partly from a Los Angeles distribution center fire. The company received a $45 million U.S. tariff refund and expects $150 million gross input-cost headwinds in H2.

$KMBMedAI 8/10

Kimberly-Clark Q2 Earnings Rise Y/Y, Gross Margin Expands

Kimberly-Clark (KMB) reported Q2 2026 adjusted EPS of $2.12, up 10.4% y/y, and sales of $4,189 million, up 0.6% but below the $4,232 million Zacks estimate. Adjusted gross margin rose 190 bps to 38.8%. The company forecasts 2026 organic sales growth about 100 bps below category growth, with mid-single-digit adjusted operating profit growth.

$KMBMedAI 8/10

Kimberly-Clark Q2 Net Income Declines

Kimberly-Clark (KMB) reported Q2 net income of $345 million versus $509 million a year earlier. EPS attributable to Kimberly-Clark was $1.04 versus $1.53. Net sales were $4.2 billion, up 0.6%, with organic sales broadly flat. The company expects 2026 adjusted operating profit to grow mid-single digits and adjusted EPS from continuing operations to rise high single digits on a constant-currency basis.